The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 07, 2018

Filed:

Mar. 18, 2014
Applicant:

Resvo Inc., Ota-ku, JP;

Inventors:

Arata Ohnishi, Chiba, JP;

Takafumi Minamimoto, Chiba, JP;

Tetsuya Suhara, Chiba, JP;

Assignee:

RESVO INC., Ota-Ku, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/567 (2006.01); G01N 33/68 (2006.01); C07K 16/42 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6857 (2013.01); C07K 16/42 (2013.01); G01N 33/6863 (2013.01); G01N 33/6869 (2013.01); G01N 33/6893 (2013.01); G01N 33/6896 (2013.01); G01N 2333/525 (2013.01); G01N 2333/545 (2013.01); G01N 2333/5412 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/301 (2013.01); G01N 2800/302 (2013.01); G01N 2800/304 (2013.01);
Abstract

The purpose of the present invention is to provide: a biomarker for psychiatric and neurological disorders, in particular, a biomarker for diagnosing psychiatric and neurological disorders; and a test kit and test method for psychiatric and neurological disorders. The inventors discovered that there is a significant increase in the concentration of free κ immunoglobulin chains and free λ immunoglobulin chains in the blood samples from patients with psychiatric and neurological disorders. Consequently, the present invention provides a biomarker for psychiatric and neurological disorders that includes at least one selected from the group consisting of free κ immunoglobulin chains, free λ immunoglobulin chains, and fragments thereof. Using this biomarker for psychiatric and neurological disorders enables the psychiatric and neurological disorders to be easily tested and diagnosed with the blood samples from the subjects. The biomarker enables more effective tests and diagnoses to be conducted combining inflammatory cytokines in the blood of patients with psychiatric and neurological disorders.


Find Patent Forward Citations

Loading…